Get the content you want anytime you want.
REGISTER NOW | SIGN IN
The Best Infectious Disease News Delivered Weekly

The Contagion® Sexually Transmitted Diseases (STD) specialty page provides STD-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

SEXUALLY TRANSMITTED DISEASES NEWS - Page 5

Low Dose Hydrocortisone Found to Enhance Cognitive Function in Women with HIV
Findings from a recent study find enduring effects of LDH on learning and memory, suggesting potential clinical utility in women with HIV.
Co-Infection with HIV Means Less Likelihood of Cancer Treatment
The advent of antiretroviral therapy has increased lifespans for those with HIV, meaning there’s a greater need to address the rising incidence of cancer in this aging population.
1 in 4 Die of Acute Infections in South African City with High HIV Rate
New research suggests that too many patients with acute infections are dying in one South African city affected by high rates of HIV and TB.
HIV Prevention and Treatment Efforts Go High-Tech in New York
Primary care physicians are using an innovative heatmap, customized web-based software, and an extensive survey to reduce the number of new HIV diagnoses and increase viral suppression rates in patients with HIV.
Top 5 Infectious Disease News of the Week—May 13, 2018
In case you missed them, we've compiled the top five infectious disease articles from this past week.
Some Patients with HIV Can Maintain Optimal Viral Loads with Fewer Primary Care Visits
Study finds some patients may be able to go up to 9 months between care visits without an impact on viral load, while other patients need to maintain the current recommended rate of <6 months between visits.
Already Reeling Venezuela Faces a New Challenge: An HIV Outbreak—Public Health Watch
With drug shortages and rising incidence of HIV/AIDS, the South American country may be on the verge of a public health crisis.
FDA Approves Truvada for Use in Adolescents
The US Food and Drug Administration (FDA) has approved once-daily oral Truvada to reduce the risk of sexually acquired HIV-1 in at-risk adolescents, in combination with safe-sex practices.